Tommy G. Thompson - 10 Sep 2025 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
10 Sep 2025
Transactions value $
-$791,388
Form type
4
Filing time
10 Sep 2025, 16:30:35
Previous filing
28 Jul 2025
Next filing
05 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Thompson Tommy G Director C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 10 Sep 2025 0001324863

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $1.05M +4.56K +53.77% $229.81 13K 10 Sep 2025 Direct F1
transaction UTHR Common Stock Sale -$1.84M -4.56K -34.97% $403.36 8.48K 10 Sep 2025 Direct F1
holding UTHR Common Stock 8.2K 10 Sep 2025 by Trust
holding UTHR Common Stock 5.8K 10 Sep 2025 Family LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Option Options Exercise $0 -4.56K -100% $0.00 0 10 Sep 2025 Common Stock 4.56K $229.81 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 880 shares of common stock to be issued on or about July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.